QuadMix Injectable recall: Sterility Concern
QuadMix Injectable (PGE1/Papaverine HCl/Phentolamine Mesylate/Atropine) 20mcg/20mg/2mg/0.2mg/mL INJECTABLE, 2.5 mL Multiple-Dose vials, Rx Only…
Why was QuadMix Injectable recalled?
Lack of Assurance of Sterility
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot#: 11292022@12, Exp 1/13/2023
- Product
- QuadMix Injectable (PGE1/Papaverine HCl/Phentolamine Mesylate/Atropine) 20mcg/20mg/2mg/0.2mg/mL INJECTABLE, 2.5 mL Multiple-Dose vials, Rx Only…
- Recalling firm
- Northern VA Compounders PLLC
- Quantity
- 2 vials
- Distribution
- Nationwide in the USA
- Recall date
- January 18, 2023
- Classification
- Class II
- Status
- Terminated
- Agency
- FDA (drug)